0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
0.41
P/E of 0.41 while CRN.AX has no earnings. Bruce Berkowitz would examine earnings quality advantage.
3.74
P/S of 3.74 while CRN.AX has no sales. Bruce Berkowitz would examine revenue quality advantage.
3.23
P/B of 3.23 while CRN.AX has zero book value. Bruce Berkowitz would examine asset quality advantage.
-9.55
Negative FCF while CRN.AX shows P/FCF of 0.00. Joel Greenblatt would examine cash flow improvement potential.
719.07
P/OCF of 719.07 while CRN.AX has no operating cash flow. Bruce Berkowitz would examine operational advantage.
3.23
Fair value ratio of 3.23 while CRN.AX has zero value. Bruce Berkowitz would examine valuation methodology.
61.13%
Earnings yield 7-10% - Fair value range. Seth Klarman would verify if yield provides sufficient margin of safety. Check Operating Margins.
-10.48%
Negative FCF while CRN.AX shows yield of 0.00%. Joel Greenblatt would examine cash flow improvement potential.